Expression of TrkB has also been associated with poor tumor pathological grade or advanced tumor stage in several solid tumor entities including ovarian cancer, lung cancer and colorectal carcinoma [23], [35], [36], however, our exploratory clinical study could not confirm this association statistically in EC. Here, NTRK2 is linked to ovarian carcinoma.